Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

sl8

(15,312 posts)
Tue Apr 23, 2024, 09:15 AM Apr 23

Alzheimer's drug adoption in US slowed by doctors' skepticism

https://www.reuters.com/business/healthcare-pharmaceuticals/alzheimers-drug-adoption-us-slowed-by-doctors-skepticism-2024-04-23/

Alzheimer's drug adoption in US slowed by doctors' skepticism

By Julie Steenhuysen
April 23, 2024 9:03 AM EDT Updated 8 min ago

CHICAGO, April 23 (Reuters) - Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, Eisai and Biogen's Leqembi is facing an unexpected hurdle to widespread use: an entrenched belief among some doctors that treating the memory-robbing disease is futile.

Alzheimer's experts had anticipated bottlenecks due to Leqembi's requirements, which include additional diagnostic tests, twice-monthly infusions and regular brain scans to guard against potentially lethal side effects.

And those issues have played a role in slow adoption since the drug was approved by the U.S. Food and Drug Administration, according to interviews with 20 neurologists and geriatricians from rural, urban, academic and community practices in 19 states.

In interviews with Reuters, seven doctors treating patients for Alzheimer's attributed their own reluctance to prescribe Leqembi to concerns about the drug's efficacy, cost and risks.

[...]

3 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Alzheimer's drug adoption in US slowed by doctors' skepticism (Original Post) sl8 Apr 23 OP
There's a lot of money in caring for Alzheimer's patients. Autumn Apr 23 #1
Sad news that the drug is so inaccessible sybylla Apr 23 #2
You omitted this part: "to guard against potentially lethal side effects" elias7 Apr 23 #3

sybylla

(8,637 posts)
2. Sad news that the drug is so inaccessible
Tue Apr 23, 2024, 09:40 AM
Apr 23

Brain scans and infusions twice a month is quite a burden for family not just in cost but in time.

elias7

(4,098 posts)
3. You omitted this part: "to guard against potentially lethal side effects"
Tue Apr 23, 2024, 10:06 AM
Apr 23

In time, with appropriate study and safeguarding, an effective drug will become more accessible. It would also be sad news indeed if your loved one died or deteriorated prematurely because of a rush to get a drug to mass market.

Latest Discussions»Issue Forums»Health»Alzheimer's drug adoption...